Requirements of phosphatidylinositol-3 kinase and mammalian target of rapamycin for estrogen-induced proliferation in uterine leiomyoma- and myometrium-derived cell lines

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 2, 2007, Pages 176.e1-176.e5

  Yin, Xuejun J ^a   Wang, Gangduo ^a   Khan Dawood, Firyal S ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

17 estradiol; mammalian target of rapamycin; phosphatidylinositol 3 kinase; proliferation; uterine leiomyomas

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ESTRADIOL; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN;

ANALYTIC METHOD; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAMMAL CELL; MITOSIS INHIBITION; MYOMETRIUM; PRIORITY JOURNAL; UTERUS MYOMA;

EID: 33846963526     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.09.037     Document Type: Article

References (15)

1. Wilcox L.S., Koonin L.M., Pokras R., Strauss L.T., Xia Z., and Peterson H.B. Hysterectomy in the United States, 1988-1990. Obstet Gynecol 83 (1994) 549-555
2. Flake G.P., Andersen J., and Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 111 (2003) 1037-1054
3. Falkenstein E., Tillmann H.C., Christ M., Feuring M., and Wehling M. Multiple actions of steroid hormones-a focus on rapid, nongenomic effects. Pharmacol Rev 52 (2000) 513-556
4. Luo J., Manning B.D., and Cantley L.C. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4 (2003) 257-262
5. Hay N., and Sonenberg N. Upstream and downstream of mTOR. Genes Dev 18 (2004) 1926-1945
6. Grewe M., Gansauge F., Schmid R.M., Adler G., and Seufferlein T. Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70s6K pathway in human pancreatic cancer cells. Cancer Res 59 (1999) 3581-3587
7. Gao N., Zhang Z., Jiang B.H., and Shi X. Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer. Biochem Biophys Res Commun 310 (2003) 1124-1132
8. Gao N., Flynn D.C., Zhang Z., et al. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. Am J Physiol Cell Physiol 287 (2004) C281-C291
9. Carney S.A., Tahara H., Swartz C.D., et al. Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics. Lab Invest 82 (2002) 719-728
10. Howe S.R., Gottardis M.M., Everitt J.I., and Walker C. Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo. Endocrinology 136 (1995) 4996-5003
11. Loy C.J., Evelyn S., Lim F.K., Liu M.H., and Yong E.L. Growth dynamics of human leiomyoma cells and inhibitory effects of the peroxisome proliferator-activated receptor-gamma ligand, pioglitazone. Mol Hum Reprod 11 (2005) 561-566
12. Burroughs K.D., Fuchs-Young R., Davis B., and Walker C.L. Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat. Biol Reprod 63 (2000) 1322-1330
13. Fukuhara K., Kariya M., Kita M., et al. Secreted frizzled related protein 1 is overexpressed in uterine leiomyomas, associated with a high estrogenic environment and unrelated to proliferative activity. J Clin Endocrinol Metab 87 (2002) 1729-1736
14. Wakeling A.E., Dukes M., and Bowler J. A potent specific pure antiestrogen with clinical potential. Cancer Res 51 (1991) 3867-3873
15. Kovacs K.A., Lengyel F., Kornyei J.L., et al. Differential expression of Akt/protein kinase B, Bcl-2 and Bax proteins in human leiomyoma and myometrium. J Steroid Biochem Mol Biol 87 (2003) 233-240